Milestones in neuroimaging
Identifieur interne : 001552 ( Main/Curation ); précédent : 001551; suivant : 001553Milestones in neuroimaging
Auteurs : A. Jon Stoessl [Canada] ; David J. Brooks [Royaume-Uni] ; David Eidelberg [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2011-05.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Brain (pathology), Diagnostic Imaging (history), Diagnostic Imaging (methods), Diagnostic Imaging (trends), Dopamine, Dystonia, Emission tomography, History, 20th Century, History, 21st Century, Humans, Huntington disease, Movement Disorders (diagnosis), Nervous system diseases, Parkinson's, Positron emission tomography, dopamine, dystonia, positron emission tomography.
- MESH :
- diagnosis : Movement Disorders.
- history : Diagnostic Imaging.
- methods : Diagnostic Imaging.
- pathology : Brain.
- trends : Diagnostic Imaging.
- History, 20th Century, History, 21st Century, Humans.
Abstract
In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease. © 2011 Movement Disorder Society
Url:
DOI: 10.1002/mds.23679
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001355
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :001355
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000284
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001184
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001184
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001235
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :003244
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :003244
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003244
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :001605
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000579
- to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :002739
- to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000514
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :001B04
Links to Exploration step
ISTEX:47D62F0F7B5893EACFD5ABA313611B87A63FFDD7Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Milestones in neuroimaging</title><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name></author><author><name sortKey="Brooks, David J" sort="Brooks, David J" uniqKey="Brooks D" first="David J." last="Brooks">David J. Brooks</name></author><author><name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:47D62F0F7B5893EACFD5ABA313611B87A63FFDD7</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/mds.23679</idno><idno type="url">https://api.istex.fr/document/47D62F0F7B5893EACFD5ABA313611B87A63FFDD7/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001355</idno><idno type="wicri:Area/Istex/Curation">001355</idno><idno type="wicri:Area/Istex/Checkpoint">000284</idno><idno type="wicri:doubleKey">0885-3185:2011:Stoessl A:milestones:in:neuroimaging</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:21626537</idno><idno type="wicri:Area/PubMed/Corpus">001184</idno><idno type="wicri:Area/PubMed/Curation">001184</idno><idno type="wicri:Area/PubMed/Checkpoint">001235</idno><idno type="wicri:Area/Ncbi/Merge">003244</idno><idno type="wicri:Area/Ncbi/Curation">003244</idno><idno type="wicri:Area/Ncbi/Checkpoint">003244</idno><idno type="wicri:Area/Main/Merge">001605</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:11-0264645</idno><idno type="wicri:Area/PascalFrancis/Corpus">000579</idno><idno type="wicri:Area/PascalFrancis/Curation">002739</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000514</idno><idno type="wicri:doubleKey">0885-3185:2011:Stoessl A:milestones:in:neuroimaging</idno><idno type="wicri:Area/Main/Merge">001B04</idno><idno type="wicri:Area/Main/Curation">001552</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Milestones in neuroimaging</title><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health, Vancouver, British Columbia</wicri:regionArea><wicri:noRegion>British Columbia</wicri:noRegion></affiliation></author><author><name sortKey="Brooks, David J" sort="Brooks, David J" uniqKey="Brooks D" first="David J." last="Brooks">David J. Brooks</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Neurosciences, Feinstein Institute for Medical Research, Manhasset, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-05">2011-05</date><biblScope unit="vol">26</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="868">868</biblScope><biblScope unit="page" to="978">978</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">47D62F0F7B5893EACFD5ABA313611B87A63FFDD7</idno><idno type="DOI">10.1002/mds.23679</idno><idno type="ArticleID">MDS23679</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Brain (pathology)</term><term>Diagnostic Imaging (history)</term><term>Diagnostic Imaging (methods)</term><term>Diagnostic Imaging (trends)</term><term>Dopamine</term><term>Dystonia</term><term>Emission tomography</term><term>History, 20th Century</term><term>History, 21st Century</term><term>Humans</term><term>Huntington disease</term><term>Movement Disorders (diagnosis)</term><term>Nervous system diseases</term><term>Parkinson's</term><term>Positron emission tomography</term><term>dopamine</term><term>dystonia</term><term>positron emission tomography</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Movement Disorders</term></keywords><keywords scheme="MESH" qualifier="history" xml:lang="en"><term>Diagnostic Imaging</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Diagnostic Imaging</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Diagnostic Imaging</term></keywords><keywords scheme="MESH" xml:lang="en"><term>History, 20th Century</term><term>History, 21st Century</term><term>Humans</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Chorée de Huntington</term><term>Dopamine</term><term>Dystonie</term><term>Pathologie du système nerveux</term><term>Tomographie par émission de positons</term><term>Tomoscintigraphie</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease. © 2011 Movement Disorder Society</div></front></TEI><double idat="0885-3185:2011:Stoessl A:milestones:in:neuroimaging"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Milestones in Neuroimaging</title><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health</s1><s2>Vancouver, British Columbia</s2><s3>CAN</s3><sZ>1 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Vancouver, British Columbia</wicri:noRegion></affiliation></author><author><name sortKey="Brooks, David J" sort="Brooks, David J" uniqKey="Brooks D" first="David J." last="Brooks">David J. Brooks</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital</s1><s2>London</s2><s3>GBR</s3><sZ>2 aut.</sZ></inist:fA14><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name><affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Center for Neurosciences, Feinstein Institute for Medical Research</s1><s2>Manhasset, New York</s2><s3>USA</s3><sZ>3 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">État de New York</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">11-0264645</idno><date when="2011">2011</date><idno type="stanalyst">PASCAL 11-0264645 INIST</idno><idno type="RBID">Pascal:11-0264645</idno><idno type="wicri:Area/PascalFrancis/Corpus">000579</idno><idno type="wicri:Area/PascalFrancis/Curation">002739</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000514</idno><idno type="wicri:doubleKey">0885-3185:2011:Stoessl A:milestones:in:neuroimaging</idno><idno type="wicri:Area/Main/Merge">001B04</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Milestones in Neuroimaging</title><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health</s1><s2>Vancouver, British Columbia</s2><s3>CAN</s3><sZ>1 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Vancouver, British Columbia</wicri:noRegion></affiliation></author><author><name sortKey="Brooks, David J" sort="Brooks, David J" uniqKey="Brooks D" first="David J." last="Brooks">David J. Brooks</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital</s1><s2>London</s2><s3>GBR</s3><sZ>2 aut.</sZ></inist:fA14><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name><affiliation wicri:level="2"><inist:fA14 i1="03"><s1>Center for Neurosciences, Feinstein Institute for Medical Research</s1><s2>Manhasset, New York</s2><s3>USA</s3><sZ>3 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">État de New York</region></placeName></affiliation></author></analytic><series><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dopamine</term><term>Dystonia</term><term>Emission tomography</term><term>Huntington disease</term><term>Nervous system diseases</term><term>Positron emission tomography</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Dystonie</term><term>Chorée de Huntington</term><term>Pathologie du système nerveux</term><term>Dopamine</term><term>Tomoscintigraphie</term><term>Tomographie par émission de positons</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease.</div></front></TEI></INIST><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Milestones in neuroimaging</title><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name></author><author><name sortKey="Brooks, David J" sort="Brooks, David J" uniqKey="Brooks D" first="David J." last="Brooks">David J. Brooks</name></author><author><name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:47D62F0F7B5893EACFD5ABA313611B87A63FFDD7</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/mds.23679</idno><idno type="url">https://api.istex.fr/document/47D62F0F7B5893EACFD5ABA313611B87A63FFDD7/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001355</idno><idno type="wicri:Area/Istex/Curation">001355</idno><idno type="wicri:Area/Istex/Checkpoint">000284</idno><idno type="wicri:doubleKey">0885-3185:2011:Stoessl A:milestones:in:neuroimaging</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:21626537</idno><idno type="wicri:Area/PubMed/Corpus">001184</idno><idno type="wicri:Area/PubMed/Curation">001184</idno><idno type="wicri:Area/PubMed/Checkpoint">001235</idno><idno type="wicri:Area/Ncbi/Merge">003244</idno><idno type="wicri:Area/Ncbi/Curation">003244</idno><idno type="wicri:Area/Ncbi/Checkpoint">003244</idno><idno type="wicri:Area/Main/Merge">001605</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Milestones in neuroimaging</title><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health, Vancouver, British Columbia</wicri:regionArea><wicri:noRegion>British Columbia</wicri:noRegion></affiliation></author><author><name sortKey="Brooks, David J" sort="Brooks, David J" uniqKey="Brooks D" first="David J." last="Brooks">David J. Brooks</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Centre for Neuroscience, Department of Medicine, Imperial College, Hammersmith Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Eidelberg, David" sort="Eidelberg, David" uniqKey="Eidelberg D" first="David" last="Eidelberg">David Eidelberg</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Neurosciences, Feinstein Institute for Medical Research, Manhasset, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-05">2011-05</date><biblScope unit="vol">26</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="868">868</biblScope><biblScope unit="page" to="978">978</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">47D62F0F7B5893EACFD5ABA313611B87A63FFDD7</idno><idno type="DOI">10.1002/mds.23679</idno><idno type="ArticleID">MDS23679</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Brain (pathology)</term><term>Diagnostic Imaging (history)</term><term>Diagnostic Imaging (methods)</term><term>Diagnostic Imaging (trends)</term><term>History, 20th Century</term><term>History, 21st Century</term><term>Humans</term><term>Huntington disease</term><term>Movement Disorders (diagnosis)</term><term>Parkinson's</term><term>dopamine</term><term>dystonia</term><term>positron emission tomography</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Movement Disorders</term></keywords><keywords scheme="MESH" qualifier="history" xml:lang="en"><term>Diagnostic Imaging</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Diagnostic Imaging</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Diagnostic Imaging</term></keywords><keywords scheme="MESH" xml:lang="en"><term>History, 20th Century</term><term>History, 21st Century</term><term>Humans</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In the last 25 years there have been enormous advances in brain imaging. In addition to utility in diagnosis, these have led to novel insights into the pathogenesis of basal ganglia disease and the role of dopamine and the basal ganglia in normal health. The authors review highlights of this work, with a focus on advances in Parkinson's disease, the dystonias, Huntington's disease, and the role of dopamine in cognition and reward signaling. Emerging areas for future development include studies of functional connectivity, the analysis of default mode networks, studies of novel neurochemical pathways, methods to study disease pathogenesis, and the application of imaging techniques to investigate animal models of disease. © 2011 Movement Disorder Society</div></front></TEI></ISTEX></double></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001552 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001552 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Curation
|type= RBID
|clé= ISTEX:47D62F0F7B5893EACFD5ABA313611B87A63FFDD7
|texte= Milestones in neuroimaging
}}
| This area was generated with Dilib version V0.6.23. |  |